局部糖酵解抑制恢复单纯疱疹性角膜炎MAVS相关抗病毒信号
本研究探讨局部糖酵解抑制能否恢复线粒体抗病毒信号(MAVS)相关先天抗病毒信号并改善单纯疱疹性角膜炎(HSK)结局。体外和体内实验显示HK2表达升高,HK2敲低或2-DG抑制减少HSV-1复制并激活TBK1/IRF3通路,局部2-DG改善小鼠角膜上皮完整性、减少病毒蛋白且疗效与阿昔洛韦相当。结论提示局部糖酵解抑制通过MAVS介导的I型干扰素信号增强角膜抗病毒防御。
要点
- HSK模型中HK2表达升高,HK2敲低或2-DG抑制减少HSV-1复制。
- HK2与MAVS蛋白存在相互作用,HK2抑制激活TBK1/IRF3通路。
- 局部2-DG改善小鼠角膜上皮完整性并减少病毒蛋白,疗效与阿昔洛韦相当。
核心结论
- 局部糖酵解抑制通过MAVS介导的I型IFN信号增强角膜抗病毒防御,控制HSV-1并减轻疾病。
研究设计与样本
- 建立体外和体内HSV-1 McKrae株感染模型,用慢病毒构建稳定HK2敲低的人角膜上皮细胞系。
- 通过WB、IF、ELISA、RT-PCR分析蛋白/mRNA水平,Co-IP确认蛋白相互作用,小鼠角膜经裂隙灯成像、IF和WB评估。
主要发现
- HSK模型中检测到HK2表达升高。
- HK2敲低或2-DG介导的抑制减少HSV-1复制(ICP0降低、ISG56升高)。
- Co-IP确认HK2与MAVS蛋白相互作用,HK2抑制激活TBK1/IRF3通路。
- 局部应用2-DG改善小鼠角膜上皮完整性、减少病毒蛋白(糖蛋白D、ICP0),疗效与阿昔洛韦相当。
关键数值与推荐
- HK2敲低或2-DG抑制后HSV-1复制减少表现为ICP0降低、ISG56升高。
- 局部2-DG在小鼠中疗效与阿昔洛韦相当。
临床怎么用
- 提示HK2可作为HSK治疗靶点,支持代谢疗法用于HSK及眼部疱疹病毒感染。
局限性
- 原文未明确报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Herpes simplex keratitis (HSK) is a leading cause of infectious corneal blindness. Host antiviral responses, particularly type I interferon (IFN) signaling, are impaired during corneal herpes simplex virus type 1 (HSV-1) infection, partly due to viral immune evasion and metabolic reprogramming. This study investigated if topical glycolysis inhibition restores mitochondrial antiviral signaling (MAVS)-associated innate antiviral signaling and improves HSK outcomes. METHODS: In vitro and in vivo infection models were established using the HSV-1 McKrae strain. A stable hexokinase 2 (HK2)-knockdown human corneal epithelial cell (HCEC) line was generated using lentivirus. Protein/mRNA levels were analyzed via western blot (WB), immunofluorescence (IF), enzyme linked immunosorbent assay (ELISA) and real-time polymerase chain reaction (RT-PCR). Protein interactions were confirmed by co-immunoprecipitation (Co-IP). Murine corneal pathology and viral proteins were assessed by slit-lamp imaging, IF, and WB. RESULTS: Elevated HK2 expression was detected in HSK models. HK2 knockdown or 2-deoxy-d-glucose (2-DG)-mediated inhibition reduced HSV-1 replication (lower infected cell protein 0 [ICP0], higher interferon-stimulated gene 56 [ISG56]). Co-IP confirmed the interaction between HK2 and MAVS protein, and HK2 inhibition activated the TANK-binding kinase 1 (TBK1)/interferon regulatory factor 3 (IRF3) pathway. Topical application of 2-DG improved murine corneal epithelial integrity, reduced viral proteins (glycoprotein D, ICP0), and showed efficacy comparable to acyclovir. CONCLUSIONS: Topical glycolysis inhibition enhances corneal antiviral defenses via MAVS-mediated type I IFN signaling, controlling HSV-1 and alleviating disease. It reveals a novel corneal metabolism-antiviral immunity link, highlights HK2 as a therapeutic target for HSK, and supports metabolic therapies for HSK and ocular herpes virus infections.
引用
- Xu W, Liu H, Cheng Z, et al. Topical Glycolysis Inhibition Restores MAVS-Associated Antiviral Signaling in Herpes Simplex Keratitis. Invest Ophthalmol Vis Sci. 2026. PMID: 42530913. doi:10.1167/iovs.67.8.63
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。